Kingyin Lee MHRA
Dr Kingyin Lee is the Head of Clinical Trials at the Medicines and Healthcare products Regulatory Agency.
He joined the MHRA in May 2024 after five years of clinical development as an investigator.
His specialisation is in early-phase and First-into-Human clinical trials, complemented by late-phase medical monitoring.
Before this, he worked as a clinician in the UK NHS for ten years.
Kingyin holds an MBPhD from UCL, a PhD in Developmental Biology and a BEng in Biochemical Engineering.